{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:47:28Z","timestamp":1793202448193,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ijid.2018.03.022","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T12:44:27Z","timestamp":1523277867000},"page":"59-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"special_numbering":"C","title":["Bloodstream infections in cancer patients. Risk factors associated with mortality"],"prefix":"10.1016","volume":"71","author":[{"given":"Beda","family":"Islas-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Volkow-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Ibanes-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Villamar-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8564-8735","authenticated-orcid":false,"given":"Diana","family":"Vilar-Compte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6331-8372","authenticated-orcid":false,"given":"Patricia","family":"Cornejo-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2018.03.022_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035780","article-title":"Molecular analysis and risk factors for Escherichia coli producing extended-spectrum \u03b2-lactamase bloodstream infection in hematological malignancies","volume":"7","author":"Cornejo-Ju\u00e1rez","year":"2012","journal-title":"PLoS One"},{"issue":"Suppl. 4","key":"10.1016\/j.ijid.2018.03.022_bib0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0213-005X(11)70036-2","article-title":"Update on bacteraemia in oncology and hematology","volume":"29","author":"Fort\u00fan","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijid.2018.03.022_bib0015","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","article-title":"Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients","volume":"19","author":"Gudiol","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2018.03.022_bib0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ajic.2017.02.023","article-title":"Microbiology of surgical site infections in patients with cancer: a 7-year review","volume":"45","author":"Hernaiz-Leonardo","year":"2017","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijid.2018.03.022_bib0025","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.49.2.760-766.2005","article-title":"Bloodstream infections caused by antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome","volume":"49","author":"Kang","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2018.03.022_bib0030","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/1471-2334-14-272","article-title":"Bloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcome","volume":"14","author":"Koupetori","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2018.03.022_bib0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2018.03.022_bib0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jinf.2014.05.018","article-title":"Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours","volume":"69","author":"Mar\u00edn","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2018.03.022_bib0045","first-page":"2417","article-title":"Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia-species distribution and susceptibility patterns","volume":"21","author":"Miedema","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijid.2018.03.022_bib0050","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","article-title":"Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance","volume":"32","author":"Montassier","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2018.03.022_bib0055","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/sur.2013.189","article-title":"Risk factors for extended spectrum \u03b2-lactamase-producing Escherichia coli versus susceptible E. coli in surgical site infections among cancer patients in Mexico","volume":"15","author":"Montes","year":"2014","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijid.2018.03.022_bib0060","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1186\/s13104-015-1701-z","article-title":"Bloodstream infections in patients with malignancies: implications for antibiotic treatment in a Ghanaian tertiary setting","volume":"8","author":"Obeng-Nkrumah","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.ijid.2018.03.022_bib0065","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1017\/ice.2015.101","article-title":"Carbapenems versus Piperacillin-Tazobactam for bloodstream infections of non-urinary source caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae","volume":"36","author":"Ofer-Friedman","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijid.2018.03.022_bib0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2334-12-245","article-title":"Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study","volume":"12","author":"Peralta","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2018.03.022_bib0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/AAC.00462-11","article-title":"Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis","volume":"56","author":"Retamar","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2018.03.022_bib0080","doi-asserted-by":"crossref","first-page":"e606","DOI":"10.1016\/S1470-2045(14)70344-4","article-title":"Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria","volume":"15","author":"Ruhnke","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijid.2018.03.022_bib0085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jinf.2016.07.002","article-title":"Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies","volume":"73","author":"Satlin","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2018.03.022_bib0090","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/jac\/dkt002","article-title":"Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of Ciprofloxacin use on antimicrobial resistance","volume":"68","author":"Schelenz","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2018.03.022_bib0095","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1086\/671281","article-title":"Mucosal barrier injury laboratory-confirmed blood infection: results from a field test of a new national healthcare safety network definition","volume":"34","author":"See","year":"2013","journal-title":"Infect Hosp Control Epidemiol"},{"issue":"4","key":"10.1016\/j.ijid.2018.03.022_bib0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","article-title":"Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey","volume":"21","author":"Trecarichi","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2018.03.022_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10096-005-0077-8","article-title":"Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections","volume":"25","author":"Velasco","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197121830081X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197121830081X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:38:59Z","timestamp":1761118739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197121830081X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":21,"alternative-id":["S120197121830081X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2018.03.022","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bloodstream infections in cancer patients. Risk factors associated with mortality","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2018.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}